Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMC Samsung Volvo
you are here:

SBI Healthcare Opportunities Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : SBI Mutual Fund
  • NAV
    : ₹ 197.4943 -0.37%
    (as on 22nd January, 2021)
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High
(Min ₹500 for SIP, ₹5000 for one time investment)

Fund has 98.88% investment in indian stocks of which 55.86% is in large cap stocks, 16.64% is in mid cap stocks, 23.97% in small cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    S&P BSE Healthcare
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • S&P BSE Healthcare : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 22nd January, 2021)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 15-Jan-21 9752.10 -2.48% - -1.25% 93/120
1 Month 22-Dec-20 10353.60 3.54% - 6.67% 103/119
3 Month 22-Oct-20 11130.80 11.31% - 21.42% 104/114
6 Month 22-Jul-20 13247.20 32.47% - 30.02% 33/113
YTD 01-Jan-21 9946.00 -0.54% - 2.65% 101/121
1 Year 22-Jan-20 16098.00 60.98% 60.77% 20.69% 7/111
2 Year 22-Jan-19 16168.90 61.69% 27.12% 14.47% 14/101
3 Year 22-Jan-18 14954.80 49.55% 14.34% 5.66% 12/87
5 Year 22-Jan-16 14279.80 42.80% 7.38% 12.81% 80/86
10 Year 21-Jan-11 43548.90 335.49% 15.83% 10.32% 8/65
Since Inception 31-Dec-04 89404.40 794.04% 14.60% 12.87% 47/128

SIP Returns (NAV as on 22nd January, 2021)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 22-Jan-20 12000 16059.6 33.83 % 67.6 %
2 Year 22-Jan-19 24000 36906.29 53.78 % 47.42 %
3 Year 22-Jan-18 36000 56568.85 57.14 % 31.57 %
5 Year 22-Jan-16 60000 92226.01 53.71 % 17.19 %
10 Year 21-Jan-11 120000 271598.33 126.33 % 15.58 %
 

Tax Treatment

Portfolio (Updated on 31st Dec,2020)

Portfolio Turnover Ratio : 70.00%  |   Category average turnover ratio is 107.25%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 98.88% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.88%
No of Stocks : 22 (Category Avg - 33.15) | Large Cap Investments : 55.86%| Mid Cap Investments : 16.64% | Small Cap Investments : 23.97% | Other : 2.41%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 1599.4 10.15% 3.38% 10.35% (Jul 2020) 4.95% (Mar 2020) 27.00 L 7.00 L
Dr. Reddys Laboratories Ltd. Pharmaceuticals 1561.5 9.91% 0.33% 10.86% (Sep 2020) 0% (Jan 2020) 3.00 L 0.00
Lupin Ltd. Pharmaceuticals 1465.3 9.30% 0.45% 9.84% (Sep 2020) 5.53% (Mar 2020) 15.00 L 0.00
Cipla Ltd. Pharmaceuticals 1410.3 8.95% 0.07% 10.25% (May 2020) 5.91% (Feb 2020) 17.20 L -0.80 L
Divis Laboratories Ltd. Pharmaceuticals 1383.1 8.78% -0.28% 9.95% (Feb 2020) 6.11% (Jul 2020) 3.60 L -0.20 L
Aurobindo Pharma Ltd. Pharmaceuticals 1382 8.77% -0.88% 9.65% (Nov 2020) 0% (Jan 2020) 15.00 L -1.80 L
Narayana Hrudayalaya Ltd. Hospital 717 4.55% 0.46% 4.55% (Dec 2020) 2.64% (May 2020) 16.00 L 0.00
Strides Pharma Science Ltd. Pharmaceuticals 658.7 4.18% 0.14% 5.39% (Jan 2020) 3.4% (Jul 2020) 7.50 L -0.50 L
Alkem Laboratories Ltd. Hospital 585.2 3.72% 0.34% 5.01% (Jan 2020) 0% (Jan 2020) 2.00 L 20.00 k
Abbott India Ltd. Pharmaceuticals 551.9 3.50% 0.95% 7.11% (Mar 2020) 2.55% (Nov 2020) 35.00 k 10.00 k
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 1.60%
Net Receivables Net Receivables -0.48%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ICICI Prudential Technology Fund - Growth 3 1184.58 9.36 21.34 61.17 69.78 26.79
DSP Healthcare Fund - Regular Plan - Growth NA 1043.27 2.30 10.30 34.17 64.62 0.00
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth NA 2159.31 1.33 10.47 29.01 62.46 0.00
Mirae Asset Healthcare Fund - Growth NA 1209.93 0.53 7.14 28.19 61.99 0.00
Franklin India Technology Fund - Growth 1 471.85 9.96 22.10 44.97 61.08 25.45
Nippon India Pharma Fund - Growth NA 4383.33 2.21 11.43 29.00 60.01 19.88
Aditya Birla Sun Life Digital India Fund - Regular Plan - Growth 4 861.20 10.39 21.61 54.68 59.56 25.60
UTI Healthcare - Growth NA 649.26 0.54 7.69 28.69 57.76 15.04
Tata Digital India Fund - Growth NA 812.53 11.52 21.00 54.09 57.41 26.20
Tata India Pharma & Heathcare Fund - Growth NA 419.33 1.64 10.68 31.43 56.28 17.94

More Funds from SBI Mutual Fund

Out of 147 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 7 is/are ranked 4 * , 15 is/are ranked 3 * , 3 is/are ranked 2 * , 6 is/are ranked 1 * , and 113 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
SBI - ETF Nifty 50 4 89441.56 6.74 21.05 29.61 19.51 10.66
SBI - ETF Nifty 50 4 89441.56 6.74 21.05 29.61 19.51 10.66
SBI Liquid Fund - Regular Plan - Growth 3 45644.20 0.23 0.72 1.54 4.02 5.90
SBI - ETF SENSEX 5 39123.31 6.26 20.70 29.47 20.17 12.17
SBI - ETF SENSEX 5 39123.31 6.26 20.70 29.47 20.17 12.17
SBI Equity Hybrid Fund - Regular Plan - Growth 4 35655.46 4.47 17.64 20.96 14.12 8.63
SBI Corporate Bond Fund - Regular Plan - Growth 3 28522.29 -0.12 0.91 2.17 9.47 0.00
SBI Blue Chip Fund - Regular Plan - Growth 3 25925.01 6.69 23.14 30.84 19.16 7.73
SBI Short Term Debt Fund - Regular Plan - Growth 3 23311.05 0.00 1.07 2.34 8.97 8.22
SBI Savings Fund - Regular Plan - Growth 1 22019.08 0.21 0.75 1.81 5.41 6.72

Forum

+ See More